Acadia Healthcare Company Inc expected to post earnings of 87 cents a share - Earnings Preview

Acadia Healthcare

29/07/2024 21:36

* Acadia Healthcare Company Inc  ACHC.OQ   ACHC.O  is
expected
to show a rise in quarterly revenue when it reports  results on
July 31 for the period ending June 30 2024
    * The Franklin Tennessee-based  company is expected to
report a
7.3% increase in revenue to $784.448 million from $731.34
million a year ago, according to the mean estimate from 10
analysts, based on LSEG data.
    * ​LSEG's mean analyst estimate for Acadia Healthcare
Company Inc
is for earnings of 87 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 9 "strong buy" or "buy," 3
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Acadia
Healthcare
Company Inc is $90.00​, above​ its last closing price of $66.59.
​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  LSEG IBES  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  ESTIMATE             MET,    SE %
               E®                               MISSED  
 Mar. 31 2024  0.81        0.81       0.84      Beat    4.2
 Dec. 31 2024  0.79        0.79       0.85      Beat    7.2
 Sep. 30 2023  0.89        0.89       0.91      Beat    2.2​
 Jun. 30 2023  0.85        0.86       0.92      Beat    7.5
 ​​Mar.        0.71        0.71       0.75      Beat    5.8
 31 2023                                                
 Dec. 31 2022  0.75        0.75       0.70      Missed  -6.6​
 Sep. 30 2022  0.79        0.79       1.64      Beat    108.5
 Jun. 30 2022  0.78        0.78       0.84      Beat    8
 This summary was machine generated July 29 at 20:36 GMT.  All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)